module 5 opiates and heroin Flashcards
factors associated with risk of overdose or addiction
long acting or ER formula: overdose combo of opioid and benzo: overdose long term use: overdose, addiction age > 65: overdose sleep disordered breathing: overdose renal or hepatic impairment: overdose depression: overdose, addiction substance use disorder: overdose, addiction hx of overdose: overdose adolescence: addiction
dx criteria for opioid use disorder
inc. amount or longer than intended use unable to cut down or control use excessive time spent to obtain, use, recover strong desire to use interference of important obligations continued use despite problems use of opioid in hazardous situation: drive need for inc. dose for effects withdrawal s/s with dose decrease
naloxone use
opiate or heroin overdose
naloxone AE
ventricular arrhythmia cardiac arrest HTN/hypoTN coma encephalopathy seizure pulmonary edema opioid withdrawal s/s
naloxone administration
intranasal - Q2-3 min until response or EMT arrival subQ IV IM - large first pass - short half life
opioids activate
my opioid receptors located on synaptic nerve terminals
- over time tolerance to euphoric effects occurs
opioid withdrawal
enhanced GABA release from inhibitory interneurones results in inhibition of dopamine neurons, dysphoria.
naltrexone MOA
partial mu opioid antagonist
- prevents high
medical detox 3 steps
- evaluation: screen and assess
- stabilization: assisting pt through intoxication and withdrawal, meds may be used,
- fostering readiness and entry into tx
methadone MOA
mu-opioid agonist
methadone uses
opioid detox
long-term relapse prevention
methadone AE
risk of addiction, misuse/abuse
respiratory depression
QT prolongation, torsades
neonatal opioid withdrawal
methadone and preg
risk of fetal harm, but benefits outweigh the risk
methadone interactions
CYP450
benzos and other CNS depressants
methadone administartion
oral, daily
buprenorephine MOA
partial mu receptor agonist
- prevents lower affinity drugs like morphine from binding
buprenorephine AE
BB: use with other CNS depressants
- sedation
- respiratory depression
- coma
- death
buprenorephine precaution
preg: prolong use in 3rd trimester -> neonatal withdrawal
buprenorpherine administration
start 12-48hrs after last opioid: precipitate withdrawal
- prevents high and alleviates cravings
buprenorphine/naloxone MOA
sublingual: naloxone inactivated, get full buprenorphine effect
injected: naloxone activated, prevents euphoria effect
buprenorphine/naloxone use
detox opioid/heroin
maintenance tx
buprenorphine/naloxone AE
precipitate or worsen withdrawal if receptor still occupied
cannabis use disorder
significant impairment in function in two or more areas within a 12 month period
cannabis behavior effect
anxiety euphoria impaired judgement impaired motor coordination social withdrawal